Found 15 matching trials
Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients PHASE2 A three sequence, open-label, multi-center, prospective, study in stable li...
Show More Location
University of Cincinnati
Learn More & Join Trial
Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily. PHASE3 Open label, prospective, single-center, randomized, two sequence, three per...
Show More Location
University of Illinois, Chicago
Learn More & Join Trial
Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients N/A Many people who receive a kidney transplant develop problems with how their...
Show More Location
Department of Nephrology, Transplantology and Internal Diseases, Medical University of Gdansk
Learn More & Join Trial
Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day. PHASE4 LCP-Tacro is an extended-release formulation of tacrolimus designed for onc...
Show More Location
Nephrology Department- Hospital Universitari Bellvtge
Learn More & Join Trial
Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients PHASE2 The purpose of this study is to demonstrate the pharmacokinetics (PK, measu...
Show More Location
LifeLink Healthcare Institute
Learn More & Join Trial
PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus PHASE4 The investigators believe that the pharmacological properties of Envarsus®,...
Show More Location
Nantes University Hospital
Learn More & Join Trial
Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients PHASE2 The purpose of this study is to demonstrate the pharmacokinetics (PK, measu...
Show More Location
University of Cincinnati
Learn More & Join Trial
Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily PHASE3 This is 2-armed parallel group, prospective, randomized, open-label, multic...
Show More Location
California Institute of Renal Research/ Sharp Memorial
Learn More & Join Trial
P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release PHASE2 Tacrolimus is a drug administered orally available with different formulati...
Show More Learn More & Join Trial
Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients PHASE2 A three sequence, open-label, multi-center, prospective, study in stable ki...
Show More Location
University of Cincinnati
Learn More & Join Trial